AKT1 and urinary bladder carcinoma: Mir-489-3p can also inhibit cell proliferation by targeting the brain-derived neurotrophic factor-mediated PI3K/AKT pathway in glioblastoma cells and suppress proliferation by targeting JAG1 in bladder cancer cells [61].